Multidisciplinary Management of Malignant Pleural Mesothelioma

Health care professionals working through this interactive patient case will gain a detailed understanding of current best practices in the management of malignant pleural mesothelioma (MPM). The patient case demonstrates the application of current guidelines on diagnosis and treatment, with a focus on the National Comprehensive Cancer Network (NCCN) guidelines. It also prompts discussion of the various treatment options for both resectable and unresectable disease, and underlines the importance of implementing a multidisciplinary approach to care.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment, or management of patients with MPM.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be better able to:

  1. Identify patients at higher risk for MPM
  2. Recall existing treatment algorithms
  3. Develop a care plan based on current treatment guidelines for the management of MPM
  4. Recognize the need for a multidisciplinary treatment approach throughout the patient journey

FACULTY

David J. Sugarbaker, MD
Baylor College of Medicine, Lung Institute, and Division of Thoracic Surgery
Baylor St. Luke’s Medical Center
Houston, TX, USA

Anne S. Tsao, MD
University of Texas MD Anderson Cancer Center
Houston, TX, USA

Acknowledgment:
Claire Patenia, PA-C from the Division of General Thoracic Surgery at Baylor College of Medicine, Houston, TX, USA, contributed to the patient case.

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose any real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

FacultyRelationship Identified With:

David J. Sugarbaker, MD

No conflicts of interest

Anne S. Tsao, MD

Consultant/Advisor: ARIAD Pharmaceuticals, Inc., AstraZeneca, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Eli Lilly and Company, EMD Serono, Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., Merck & Co., Inc, Novartis AG, Seattle Genetics, Inc., Sellas

Grant/Research Support: ARIAD Pharmaceuticals, Inc., AstraZeneca, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Epizyme®, Inc., Genentech Inc., Merck & Co., Inc, Polaris Pharmaceuticals, Inc., Seattle Genetics, Inc.

Non-faculty: Sandy Breslow; Alison Kemp; Bernard M. Abrams, MD; Marijke Verhaaf, Joke Artmanni, Elena Knoche, PhD hereby state that neither they nor their spouse/life partner have had any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Financial Support

This activity has been supported by an independent educational grant from Boehringer Ingelheim.

Provider Information

Jointly provided by the Elsevier Office of Continuing Medical Education and Excerpta Medica.

CME Credit (Physicians)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and Excerpta Medica. The Elsevier Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the Accreditation Council for Continuing Medical Education (ACCME) for the purpose of reaccreditation for both nurse practitioners and registered nurses.

The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME for Category 1 CME credit activities for physician assistants.

CME INQUIRIES/SPECIAL NEEDS

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.


Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Excerpta Medica, and Boehringer Ingelheim do not recommend the use of any agent outside of the labeled indications.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 Non-physician
Course opens: 
07/31/2018
Course expires: 
07/30/2019
Rating: 
0

Available Credit

  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 Non-physician

Accreditation Period

Course opens: 
07/31/2018
Course expires: 
07/30/2019
Please login or register to take this course.